Protheragen

Our company is a globally operating service provider and one of the world leaders in the development and delivery of advanced drug therapies for rare diseases. We not only provide global customers with a wide range of services for rare disease genomic analysis, gene therapy vector, and strategy design but also provide efficacy testing, safety, and toxicology analysis for therapeutic products.